Besides, other relevant studies pointed that the use of insulin could worsen outcomes of CRC patients with preexisting diabetes, in which the use of insulin was associated with more lymphatic metastasis and more advanced pathological stage. The gene discussed is INS; the disease is colorectal carcinoma.